Individualized PEEP Setting by EIT in Patients With ARDS
Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Feb 6, 2015
Trial Information
Current as of June 04, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion:
- • 1. acute respiratory distress syndrome with ratio of partial pressure of arterial oxygen over fraction of inspired oxygen (PaO2:FiO2)\<300 and PEEP \>5cmH2O
- • 2. Body mass index \< =40
- • 3. Written inform consent
- Exclusion:
- • 1. pregnant，intracranial hypertension
- • 2. left ventricular dysfunction (EF\<25% )
- • 3. Patients with end-stage conditions(death expected within 90 days)
About Peking Union Medical College Hospital
Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Yun Long, MD
Study Director
Department of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials